Global Infectious Disease Testing Market Size, Status and Forecast 2021-2027

SKU ID :QYR-17245623 | Published Date: 22-Jan-2021 | No. of pages: 128
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infectious Disease Testing Market Size Growth Rate by Technology: 2016 VS 2021 VS 2027 1.2.2 Immunodiagnostics 1.2.3 Clinical Microbiology 1.2.4 PCR 1.2.5 INAAT 1.2.6 DNA Sequencing & NGS 1.2.7 DNA Microarrays 1.2.8 Other 1.3 Market by Application 1.3.1 Global Infectious Disease Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals/Clinical Laboratories 1.3.3 Reference Laboratories 1.3.4 Academic/Research Institutes 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Infectious Disease Testing Market Perspective (2016-2027) 2.2 Infectious Disease Testing Growth Trends by Regions 2.2.1 Infectious Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Infectious Disease Testing Historic Market Share by Regions (2016-2021) 2.2.3 Infectious Disease Testing Forecasted Market Size by Regions (2022-2027) 2.3 Infectious Disease Testing Industry Dynamic 2.3.1 Infectious Disease Testing Market Trends 2.3.2 Infectious Disease Testing Market Drivers 2.3.3 Infectious Disease Testing Market Challenges 2.3.4 Infectious Disease Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Infectious Disease Testing Players by Revenue 3.1.1 Global Top Infectious Disease Testing Players by Revenue (2016-2021) 3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2016-2021) 3.2 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Infectious Disease Testing Revenue 3.4 Global Infectious Disease Testing Market Concentration Ratio 3.4.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2020 3.5 Infectious Disease Testing Key Players Head office and Area Served 3.6 Key Players Infectious Disease Testing Product Solution and Service 3.7 Date of Enter into Infectious Disease Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Infectious Disease Testing Breakdown Data by Technology 4.1 Global Infectious Disease Testing Historic Market Size by Technology (2016-2021) 4.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2022-2027) 5 Infectious Disease Testing Breakdown Data by Application 5.1 Global Infectious Disease Testing Historic Market Size by Application (2016-2021) 5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Infectious Disease Testing Market Size (2016-2027) 6.2 North America Infectious Disease Testing Market Size by Technology 6.2.1 North America Infectious Disease Testing Market Size by Technology (2016-2021) 6.2.2 North America Infectious Disease Testing Market Size by Technology (2022-2027) 6.2.3 North America Infectious Disease Testing Market Size by Technology (2016-2027) 6.3 North America Infectious Disease Testing Market Size by Application 6.3.1 North America Infectious Disease Testing Market Size by Application (2016-2021) 6.3.2 North America Infectious Disease Testing Market Size by Application (2022-2027) 6.3.3 North America Infectious Disease Testing Market Size by Application (2016-2027) 6.4 North America Infectious Disease Testing Market Size by Country 6.4.1 North America Infectious Disease Testing Market Size by Country (2016-2021) 6.4.2 North America Infectious Disease Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Infectious Disease Testing Market Size (2016-2027) 7.2 Europe Infectious Disease Testing Market Size by Technology 7.2.1 Europe Infectious Disease Testing Market Size by Technology (2016-2021) 7.2.2 Europe Infectious Disease Testing Market Size by Technology (2022-2027) 7.2.3 Europe Infectious Disease Testing Market Size by Technology (2016-2027) 7.3 Europe Infectious Disease Testing Market Size by Application 7.3.1 Europe Infectious Disease Testing Market Size by Application (2016-2021) 7.3.2 Europe Infectious Disease Testing Market Size by Application (2022-2027) 7.3.3 Europe Infectious Disease Testing Market Size by Application (2016-2027) 7.4 Europe Infectious Disease Testing Market Size by Country 7.4.1 Europe Infectious Disease Testing Market Size by Country (2016-2021) 7.4.2 Europe Infectious Disease Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Infectious Disease Testing Market Size (2016-2027) 8.2 Asia-Pacific Infectious Disease Testing Market Size by Technology 8.2.1 Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2021) 8.2.2 Asia-Pacific Infectious Disease Testing Market Size by Technology (2022-2027) 8.2.3 Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2027) 8.3 Asia-Pacific Infectious Disease Testing Market Size by Application 8.3.1 Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Infectious Disease Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific Infectious Disease Testing Market Size by Region 8.4.1 Asia-Pacific Infectious Disease Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Infectious Disease Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Infectious Disease Testing Market Size (2016-2027) 9.2 Latin America Infectious Disease Testing Market Size by Technology 9.2.1 Latin America Infectious Disease Testing Market Size by Technology (2016-2021) 9.2.2 Latin America Infectious Disease Testing Market Size by Technology (2022-2027) 9.2.3 Latin America Infectious Disease Testing Market Size by Technology (2016-2027) 9.3 Latin America Infectious Disease Testing Market Size by Application 9.3.1 Latin America Infectious Disease Testing Market Size by Application (2016-2021) 9.3.2 Latin America Infectious Disease Testing Market Size by Application (2022-2027) 9.3.3 Latin America Infectious Disease Testing Market Size by Application (2016-2027) 9.4 Latin America Infectious Disease Testing Market Size by Country 9.4.1 Latin America Infectious Disease Testing Market Size by Country (2016-2021) 9.4.2 Latin America Infectious Disease Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Infectious Disease Testing Market Size (2016-2027) 10.2 Middle East & Africa Infectious Disease Testing Market Size by Technology 10.2.1 Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2021) 10.2.2 Middle East & Africa Infectious Disease Testing Market Size by Technology (2022-2027) 10.2.3 Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2027) 10.3 Middle East & Africa Infectious Disease Testing Market Size by Application 10.3.1 Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Infectious Disease Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa Infectious Disease Testing Market Size by Country 10.4.1 Middle East & Africa Infectious Disease Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Infectious Disease Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Diagnostics 11.1.1 Abbott Diagnostics Company Details 11.1.2 Abbott Diagnostics Business Overview 11.1.3 Abbott Diagnostics Infectious Disease Testing Introduction 11.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) 11.1.5 Abbott Diagnostics Recent Development 11.2 Abbott 11.2.1 Abbott Company Details 11.2.2 Abbott Business Overview 11.2.3 Abbott Infectious Disease Testing Introduction 11.2.4 Abbott Revenue in Infectious Disease Testing Business (2016-2021) 11.2.5 Abbott Recent Development 11.3 Beckman Coulter Diagnostics 11.3.1 Beckman Coulter Diagnostics Company Details 11.3.2 Beckman Coulter Diagnostics Business Overview 11.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction 11.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) 11.3.5 Beckman Coulter Diagnostics Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Infectious Disease Testing Introduction 11.4.4 Roche Revenue in Infectious Disease Testing Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Siemens Healthcare 11.5.1 Siemens Healthcare Company Details 11.5.2 Siemens Healthcare Business Overview 11.5.3 Siemens Healthcare Infectious Disease Testing Introduction 11.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2016-2021) 11.5.5 Siemens Healthcare Recent Development 11.6 Abaxis 11.6.1 Abaxis Company Details 11.6.2 Abaxis Business Overview 11.6.3 Abaxis Infectious Disease Testing Introduction 11.6.4 Abaxis Revenue in Infectious Disease Testing Business (2016-2021) 11.6.5 Abaxis Recent Development 11.7 Acon Laboratories 11.7.1 Acon Laboratories Company Details 11.7.2 Acon Laboratories Business Overview 11.7.3 Acon Laboratories Infectious Disease Testing Introduction 11.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2016-2021) 11.7.5 Acon Laboratories Recent Development 11.8 Avioq 11.8.1 Avioq Company Details 11.8.2 Avioq Business Overview 11.8.3 Avioq Infectious Disease Testing Introduction 11.8.4 Avioq Revenue in Infectious Disease Testing Business (2016-2021) 11.8.5 Avioq Recent Development 11.9 BD 11.9.1 BD Company Details 11.9.2 BD Business Overview 11.9.3 BD Infectious Disease Testing Introduction 11.9.4 BD Revenue in Infectious Disease Testing Business (2016-2021) 11.9.5 BD Recent Development 11.10 Bio-Rad Laboratories 11.10.1 Bio-Rad Laboratories Company Details 11.10.2 Bio-Rad Laboratories Business Overview 11.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction 11.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2016-2021) 11.10.5 Bio-Rad Laboratories Recent Development 11.11 Cavidi 11.11.1 Cavidi Company Details 11.11.2 Cavidi Business Overview 11.11.3 Cavidi Infectious Disease Testing Introduction 11.11.4 Cavidi Revenue in Infectious Disease Testing Business (2016-2021) 11.11.5 Cavidi Recent Development 11.12 Cepheid 11.12.1 Cepheid Company Details 11.12.2 Cepheid Business Overview 11.12.3 Cepheid Infectious Disease Testing Introduction 11.12.4 Cepheid Revenue in Infectious Disease Testing Business (2016-2021) 11.12.5 Cepheid Recent Development 11.13 Chembio Diagnostic Systems 11.13.1 Chembio Diagnostic Systems Company Details 11.13.2 Chembio Diagnostic Systems Business Overview 11.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction 11.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2016-2021) 11.13.5 Chembio Diagnostic Systems Recent Development 11.14 Clarity Diagnostics 11.14.1 Clarity Diagnostics Company Details 11.14.2 Clarity Diagnostics Business Overview 11.14.3 Clarity Diagnostics Infectious Disease Testing Introduction 11.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) 11.14.5 Clarity Diagnostics Recent Development 11.15 EMD Millipore 11.15.1 EMD Millipore Company Details 11.15.2 EMD Millipore Business Overview 11.15.3 EMD Millipore Infectious Disease Testing Introduction 11.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2016-2021) 11.15.5 EMD Millipore Recent Development 11.16 Epitope Diagnostic 11.16.1 Epitope Diagnostic Company Details 11.16.2 Epitope Diagnostic Business Overview 11.16.3 Epitope Diagnostic Infectious Disease Testing Introduction 11.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2016-2021) 11.16.5 Epitope Diagnostic Recent Development 11.17 Gold Standard Diagnostics 11.17.1 Gold Standard Diagnostics Company Details 11.17.2 Gold Standard Diagnostics Business Overview 11.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction 11.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) 11.17.5 Gold Standard Diagnostics Recent Development 11.18 Hologic 11.18.1 Hologic Company Details 11.18.2 Hologic Business Overview 11.18.3 Hologic Infectious Disease Testing Introduction 11.18.4 Hologic Revenue in Infectious Disease Testing Business (2016-2021) 11.18.5 Hologic Recent Development 11.18 Immunetics .1 Immunetics Company Details .2 Immunetics Business Overview .3 Immunetics Infectious Disease Testing Introduction .4 Immunetics Revenue in Infectious Disease Testing Business (2016-2021) .5 Immunetics Recent Development 11.20 InBios International 11.20.1 InBios International Company Details 11.20.2 InBios International Business Overview 11.20.3 InBios International Infectious Disease Testing Introduction 11.20.4 InBios International Revenue in Infectious Disease Testing Business (2016-2021) 11.20.5 InBios International Recent Development 11.21 Life Technologies 11.21.1 Life Technologies Company Details 11.21.2 Life Technologies Business Overview 11.21.3 Life Technologies Infectious Disease Testing Introduction 11.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2016-2021) 11.21.5 Life Technologies Recent Development 11.22 Maxim Biomedical 11.22.1 Maxim Biomedical Company Details 11.22.2 Maxim Biomedical Business Overview 11.22.3 Maxim Biomedical Infectious Disease Testing Introduction 11.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2016-2021) 11.22.5 Maxim Biomedical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Infectious Disease Testing Market Size Growth Rate by Technology (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Immunodiagnostics Table 3. Key Players of Clinical Microbiology Table 4. Key Players of PCR Table 5. Key Players of INAAT Table 6. Key Players of DNA Sequencing & NGS Table 7. Key Players of DNA Microarrays Table 8. Key Players of Other Table 9. Global Infectious Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Infectious Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Infectious Disease Testing Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Infectious Disease Testing Market Share by Regions (2016-2021) Table 13. Global Infectious Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Infectious Disease Testing Market Share by Regions (2022-2027) Table 15. Infectious Disease Testing Market Trends Table 16. Infectious Disease Testing Market Drivers Table 17. Infectious Disease Testing Market Challenges Table 18. Infectious Disease Testing Market Restraints Table 19. Global Infectious Disease Testing Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Infectious Disease Testing Market Share by Players (2016-2021) Table 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2020) Table 22. Ranking of Global Top Infectious Disease Testing Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Infectious Disease Testing Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Infectious Disease Testing Product Solution and Service Table 26. Date of Enter into Infectious Disease Testing Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million) Table 29. Global Infectious Disease Testing Revenue Market Share by Technology (2016-2021) Table 30. Global Infectious Disease Testing Forecasted Market Size by Technology (2022-2027) (US$ Million) Table 31. Global Infectious Disease Testing Revenue Market Share by Technology (2022-2027) & (US$ Million) Table 32. Global Infectious Disease Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Infectious Disease Testing Revenue Market Share by Application (2016-2021) Table 34. Global Infectious Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Infectious Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million) Table 37. North America Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million) Table 38. North America Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 39. North America Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million) Table 43. Europe Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million) Table 44. Europe Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million) Table 49. Asia-Pacific Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million) Table 50. Asia-Pacific Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Infectious Disease Testing Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Infectious Disease Testing Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million) Table 55. Latin America Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million) Table 56. Latin America Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Infectious Disease Testing Market Size by Technology (2016-2021) (US$ Million) Table 61. Middle East & Africa Infectious Disease Testing Market Size by Technology (2022-2027) & (US$ Million) Table 62. Middle East & Africa Infectious Disease Testing Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Infectious Disease Testing Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Infectious Disease Testing Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Infectious Disease Testing Market Size by Country (2022-2027) & (US$ Million) Table 66. Abbott Diagnostics Company Details Table 67. Abbott Diagnostics Business Overview Table 68. Abbott Diagnostics Infectious Disease Testing Product Table 69. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 70. Abbott Diagnostics Recent Development Table 71. Abbott Company Details Table 72. Abbott Business Overview Table 73. Abbott Infectious Disease Testing Product Table 74. Abbott Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 75. Abbott Recent Development Table 76. Beckman Coulter Diagnostics Company Details Table 77. Beckman Coulter Diagnostics Business Overview Table 78. Beckman Coulter Diagnostics Infectious Disease Testing Product Table 79. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 80. Beckman Coulter Diagnostics Recent Development Table 81. Roche Company Details Table 82. Roche Business Overview Table 83. Roche Infectious Disease Testing Product Table 84. Roche Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 85. Roche Recent Development Table 86. Siemens Healthcare Company Details Table 87. Siemens Healthcare Business Overview Table 88. Siemens Healthcare Infectious Disease Testing Product Table 89. Siemens Healthcare Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 90. Siemens Healthcare Recent Development Table 91. Abaxis Company Details Table 92. Abaxis Business Overview Table 93. Abaxis Infectious Disease Testing Product Table 94. Abaxis Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 95. Abaxis Recent Development Table 96. Acon Laboratories Company Details Table 97. Acon Laboratories Business Overview Table 98. Acon Laboratories Infectious Disease Testing Product Table 99. Acon Laboratories Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 100. Acon Laboratories Recent Development Table 101. Avioq Company Details Table 102. Avioq Business Overview Table 103. Avioq Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 104. Avioq Recent Development Table 105. BD Company Details Table 106. BD Business Overview Table 107. BD Infectious Disease Testing Product Table 108. BD Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 109. BD Recent Development Table 110. Bio-Rad Laboratories Company Details Table 111. Bio-Rad Laboratories Business Overview Table 112. Bio-Rad Laboratories Infectious Disease Testing Product Table 113. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 114. Bio-Rad Laboratories Recent Development Table 115. Cavidi Company Details Table 116. Cavidi Business Overview Table 117. Cavidi Infectious Disease Testing Product Table 118. Cavidi Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 119. Cavidi Recent Development Table 120. Cepheid Company Details Table 121. Cepheid Business Overview Table 122. Cepheid Infectious Disease Testing Product Table 123. Cepheid Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 124. Cepheid Recent Development Table 125. Chembio Diagnostic Systems Company Details Table 126. Chembio Diagnostic Systems Business Overview Table 127. Chembio Diagnostic Systems Infectious Disease Testing Product Table 128. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 129. Chembio Diagnostic Systems Recent Development Table 130. Clarity Diagnostics Company Details Table 131. Clarity Diagnostics Business Overview Table 132. Clarity Diagnostics Infectious Disease Testing Product Table 133. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 134. Clarity Diagnostics Recent Development Table 135. EMD Millipore Company Details Table 136. EMD Millipore Business Overview Table 137. EMD Millipore Infectious Disease Testing Product Table 138. EMD Millipore Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 139. EMD Millipore Recent Development Table 140. Epitope Diagnostic Company Details Table 141. Epitope Diagnostic Business Overview Table 142. Epitope Diagnostic Infectious Disease Testing Product Table 143. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 144. Epitope Diagnostic Recent Development Table 145. Gold Standard Diagnostics Company Details Table 146. Gold Standard Diagnostics Business Overview Table 147. Gold Standard Diagnostics Infectious Disease Testing Product Table 148. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 149. Gold Standard Diagnostics Recent Development Table 150. Hologic Company Details Table 151. Hologic Business Overview Table 152. Hologic Infectious Disease Testing Product Table 153. Hologic Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 154. Hologic Recent Development Table 155. Immunetics Company Details Table 156. Immunetics Business Overview Table 157. Immunetics Infectious Disease Testing Product Table 158. Immunetics Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 159. Immunetics Recent Development Table 160. InBios International Company Details Table 161. InBios International Business Overview Table 162. InBios International Infectious Disease Testing Product Table 163. InBios International Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 164. InBios International Recent Development Table 165. Life Technologies Company Details Table 166. Life Technologies Business Overview Table 167. Life Technologies Infectious Disease Testing Product Table 168. Life Technologies Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 169. Life Technologies Recent Development Table 170. Maxim Biomedical Company Details Table 171. Maxim Biomedical Business Overview Table 172. Maxim Biomedical Infectious Disease Testing Product Table 173. Maxim Biomedical Revenue in Infectious Disease Testing Business (2016-2021) & (US$ Million) Table 174. Maxim Biomedical Recent Development Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Global Infectious Disease Testing Market Share by Technology: 2020 VS 2027 Figure 2. Immunodiagnostics Features Figure 3. Clinical Microbiology Features Figure 4. PCR Features Figure 5. INAAT Features Figure 6. DNA Sequencing & NGS Features Figure 7. DNA Microarrays Features Figure 8. Other Features Figure 9. Global Infectious Disease Testing Market Share by Application: 2020 VS 2027 Figure 10. Hospitals/Clinical Laboratories Case Studies Figure 11. Reference Laboratories Case Studies Figure 12. Academic/Research Institutes Case Studies Figure 13. Other Case Studies Figure 14. Infectious Disease Testing Report Years Considered Figure 15. Global Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Infectious Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Infectious Disease Testing Market Share by Regions: 2020 VS 2027 Figure 18. Global Infectious Disease Testing Market Share by Regions (2022-2027) Figure 19. Global Infectious Disease Testing Market Share by Players in 2020 Figure 20. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2020 Figure 22. Global Infectious Disease Testing Revenue Market Share by Technology (2016-2021) Figure 23. Global Infectious Disease Testing Revenue Market Share by Technology (2022-2027) Figure 24. North America Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Infectious Disease Testing Market Share by Technology (2016-2027) Figure 26. North America Infectious Disease Testing Market Share by Application (2016-2027) Figure 27. North America Infectious Disease Testing Market Share by Country (2016-2027) Figure 28. United States Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Infectious Disease Testing Market Share by Technology (2016-2027) Figure 32. Europe Infectious Disease Testing Market Share by Application (2016-2027) Figure 33. Europe Infectious Disease Testing Market Share by Country (2016-2027) Figure 34. Germany Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Infectious Disease Testing Market Share by Technology (2016-2027) Figure 42. Asia-Pacific Infectious Disease Testing Market Share by Application (2016-2027) Figure 43. Asia-Pacific Infectious Disease Testing Market Share by Region (2016-2027) Figure 44. China Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Infectious Disease Testing Market Share by Technology (2016-2027) Figure 52. Latin America Infectious Disease Testing Market Share by Application (2016-2027) Figure 53. Latin America Infectious Disease Testing Market Share by Country (2016-2027) Figure 54. Mexico Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Infectious Disease Testing Market Share by Technology (2016-2027) Figure 58. Middle East & Africa Infectious Disease Testing Market Share by Application (2016-2027) Figure 59. Middle East & Africa Infectious Disease Testing Market Share by Country (2016-2027) Figure 60. Turkey Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Infectious Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Abbott Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 64. Abbott Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 65. Beckman Coulter Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 66. Roche Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 67. Siemens Healthcare Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 68. Abaxis Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 69. Acon Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 70. Avioq Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 71. BD Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 72. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 73. Cavidi Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 74. Cepheid Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 75. Chembio Diagnostic Systems Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 76. Clarity Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 77. EMD Millipore Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 78. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 79. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 80. Hologic Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 81. Immunetics Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 82. InBios International Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 83. Life Technologies Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 84. Maxim Biomedical Revenue Growth Rate in Infectious Disease Testing Business (2016-2021) Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed
Abbott Diagnostics Abbott Beckman Coulter Diagnostics Roche Siemens Healthcare Abaxis Acon Laboratories Avioq BD Bio-Rad Laboratories Cavidi Cepheid Chembio Diagnostic Systems Clarity Diagnostics EMD Millipore Epitope Diagnostic Gold Standard Diagnostics Hologic Immunetics InBios International Life Technologies Maxim Biomedical
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients